Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2023 2
2024 2
2025 2
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Nailfold capillary abnormalities in VEXAS syndrome.
Nikolic RPA, Thomson SG. Nikolic RPA, et al. Clin Rheumatol. 2026 Jul;45(7):4717-4718. doi: 10.1007/s10067-026-08068-0. Epub 2026 Mar 28. Clin Rheumatol. 2026. PMID: 41904316 No abstract available.
International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseases.
Nikolic RPA, Ben-Chetrit E, Fritzler MJ, Buhler KA, Shokravi A, Barreth NH, Chan EKL, Andrade LEC, Lin M, Grewal J, Buyon J, Damoiseaux J, Lee AYS, Steiner G, Ménard HA, Boire G, Pruijn GJM, Reeves WH, Satoh M, Scofield RH, Tebo AE, Wener M, Choi MY. Nikolic RPA, et al. Ann Rheum Dis. 2026 May 14:S0003-4967(26)00228-1. doi: 10.1016/j.ard.2026.04.007. Online ahead of print. Ann Rheum Dis. 2026. PMID: 42135154 Free article.
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases.
Ye C, Nikolic RPA, Choi M, Fifi-Mah AV, Graham J, O'Neil LJ, Kobza A, Lau KCK, Arreola LG, Pardo JP, Ladouceur A, Saltman A, Velthuizen D, Khokhar F, Colmegna I, Pope JE, Roberts J, Hudson M, Himmel M, Maltez N, Hoa S, Hazlewood GS, Jamal S. Ye C, et al. Among authors: nikolic rpa. J Rheumatol. 2025 Dec 1;52(12):1218-1230. doi: 10.3899/jrheum.2025-0482. J Rheumatol. 2025. PMID: 40953951 Free article.
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2.
Nikolic RPA, Pardo JP, Pope JE, Barber CEH, Barnabe C, Schieir O, Jamal S, Legge A, Kuriya B, Akhavan P, Thorne JC, Bombardier C, Taylor-Gjevre R, Bykerk V, Khraishi M, Proulx L, Richards DP, Tugwell P, Agarwal A, Bansback N, Hazlewood GS. Nikolic RPA, et al. J Rheumatol. 2024 Sep 1;51(9):940-941. doi: 10.3899/jrheum.2024-0540. J Rheumatol. 2024. PMID: 39009382 No abstract available.
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1.
Hazlewood GS, Akhavan P, Pardo JP, Agarwal A, Schieir O, Barber CEH, Proulx L, Richards DP, Bombardier C, Pope JE, Barnabe C, Tugwell P, Jamal S, Thorne JC, Nikolic RPA, Khraishi M, Bansback N, Legge A, Bykerk V, Taylor-Gjevre R. Hazlewood GS, et al. Among authors: nikolic rpa. J Rheumatol. 2023 Sep;50(9):1198-1199. doi: 10.3899/jrheum.2023-0625. Epub 2023 Aug 1. J Rheumatol. 2023. PMID: 37527865 No abstract available.
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides.
Ye C, Nikolic RPA, Choi M, Fifi-Mah AV, Graham J, O'Neil LJ, Kobza A, Lau KCK, Arreola LG, Pardo JP, Ladouceur A, Saltman A, Velthuizen D, Khokhar F, Colmegna I, Pope JE, Roberts J, Hudson M, Himmel M, Maltez N, Hoa S, Hazlewood GS, Jamal S. Ye C, et al. Among authors: nikolic rpa. J Rheumatol. 2025 Dec 1;52(12):1207-1217. doi: 10.3899/jrheum.2025-0481. J Rheumatol. 2025. PMID: 40953945 Free article.
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3.
Nikolic RPA, Agarwal A, Pardo JP, Akhavan P, Allard-Chamard H, Barber CEH, Barnabe C, Jamal S, Kuriya B, Legge A, Pope JE, Proulx L, Richards DP, Schieir O, Taylor-Gjevre R, Thorne JC, Tugwell P, Hazlewood GS. Nikolic RPA, et al. J Rheumatol. 2026 Aug 1;53(8):932-934. doi: 10.3899/jrheum.2026-0228. J Rheumatol. 2026. PMID: 41921998 No abstract available.
Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases.
Hazlewood GS, Pardo JP, Barnabe C, Schieir O, Barber CEH, Bernatsky S, Colmegna I, Hitchon C, Loeb M, Mertz D, Proulx L, Richards DP, Scuccimarri R, Tugwell P, Schünemann HJ, Mirza RD, Zhou AL, Nikolic RPA, Thomas M, Chase H, Ejaredar M, Nieuwlaat R. Hazlewood GS, et al. Among authors: nikolic rpa. J Rheumatol. 2021 Aug;48(8):1330-1339. doi: 10.3899/jrheum.210288. Epub 2021 May 15. J Rheumatol. 2021. PMID: 33993119 Free article.